Product NDC: | 50222-342 |
Proprietary Name: | INNOHEP |
Non Proprietary Name: | tinzaparin sodium |
Active Ingredient(s): | 20000 [iU]/mL & nbsp; tinzaparin sodium |
Administration Route(s): | SUBCUTANEOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 50222-342 |
Labeler Name: | LEO Pharma Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020484 |
Marketing Category: | NDA |
Start Marketing Date: | 20100701 |
Package NDC: | 50222-342-53 |
Package Description: | 10 VIAL, MULTI-DOSE in 1 CARTON (50222-342-53) > 2 mL in 1 VIAL, MULTI-DOSE |
NDC Code | 50222-342-53 |
Proprietary Name | INNOHEP |
Package Description | 10 VIAL, MULTI-DOSE in 1 CARTON (50222-342-53) > 2 mL in 1 VIAL, MULTI-DOSE |
Product NDC | 50222-342 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | tinzaparin sodium |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | SUBCUTANEOUS |
Start Marketing Date | 20100701 |
Marketing Category Name | NDA |
Labeler Name | LEO Pharma Inc. |
Substance Name | TINZAPARIN SODIUM |
Strength Number | 20000 |
Strength Unit | [iU]/mL |
Pharmaceutical Classes | Heparin, Low-Molecular-Weight [Chemical/Ingredient],Low Molecular Weight Heparin [EPC] |